These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 19639675)
21. Efficacy and clinical safety of ramelteon: an evidence-based review. Sateia MJ; Kirby-Long P; Taylor JL Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221 [TBL] [Abstract][Full Text] [Related]
22. Drugs for insomnia. Treat Guidel Med Lett; 2009 Mar; 7(79):23-6. PubMed ID: 19229159 [No Abstract] [Full Text] [Related]
23. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Johnson MW; Suess PE; Griffiths RR Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817 [TBL] [Abstract][Full Text] [Related]
24. The effects of ramelteon in a first-night model of transient insomnia. Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937 [TBL] [Abstract][Full Text] [Related]
25. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Kuriyama A; Honda M; Hayashino Y Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955 [TBL] [Abstract][Full Text] [Related]
27. Ramelteon (Rozerem) for insomnia. Med Lett Drugs Ther; 2005 Nov; 47(1221):89-91. PubMed ID: 16267494 [No Abstract] [Full Text] [Related]
29. [Delirium, insomnia in hospitalization and ramelteon]. Ito T Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020 [TBL] [Abstract][Full Text] [Related]
30. Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Liu J; Wang LN Int J Clin Pract; 2012 Sep; 66(9):867-73. PubMed ID: 22897464 [TBL] [Abstract][Full Text] [Related]
32. Drugs for insomnia. Zisapel N Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198 [TBL] [Abstract][Full Text] [Related]
33. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Richardson G; Wang-Weigand S Hum Psychopharmacol; 2009 Mar; 24(2):103-11. PubMed ID: 19090503 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T J Clin Sleep Med; 2007 Aug; 3(5):495-504. PubMed ID: 17803013 [TBL] [Abstract][Full Text] [Related]
35. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Roth T Sleep Med; 2009 Jan; 10(1):19-25. PubMed ID: 18693067 [TBL] [Abstract][Full Text] [Related]
37. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Mini L; Wang-Weigand S; Zhang J Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991 [TBL] [Abstract][Full Text] [Related]
38. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. Wang-Weigand S; McCue M; Ogrinc F; Mini L Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100 [TBL] [Abstract][Full Text] [Related]
39. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia. Roth T; Seiden D; Wang-Weigand S; Zhang J Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067 [TBL] [Abstract][Full Text] [Related]
40. Autoimmune hepatitis in association with ramelteon. Fourman LT; Robert Meyer B J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]